1. Academic Validation
  2. Orphan nuclear receptor 4A1 (NR4A1) and NR4A2 are endogenous regulators of CD71 and their ligands induce ferroptosis in breast cancer

Orphan nuclear receptor 4A1 (NR4A1) and NR4A2 are endogenous regulators of CD71 and their ligands induce ferroptosis in breast cancer

  • Cell Death Dis. 2025 Nov 3;16(1):776. doi: 10.1038/s41419-025-08143-5.
Arafat Rahman Oany 1 Srijana Upadhyay 1 Wai Ning Tiffany Tsui 1 Amanuel Hailemariam 1 Sarah Latka 2 John D Landua 3 Sandra D Scherer 4 Alana L Welm 4 Hugo Villanueva 2 5 Michael T Lewis 2 3 Stephen Safe 6
Affiliations

Affiliations

  • 1 Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA.
  • 2 Advanced Technology Cores, Baylor College of Medicine, Houston, TX, USA.
  • 3 Breast Center, Baylor College of Medicine, Houston, TX, USA.
  • 4 Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • 5 Otolaryngology - Head and Neck Surgery, Baylor College of Medicine, Houston, TX, USA.
  • 6 Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine, Texas A&M University, College Station, TX, USA. [email protected].
Abstract

Ferroptosis is an iron-dependent cell death pathway that involves multiple genes, including the Transferrin Receptor (TFRC/CD71), Glutathione Peroxidase 4 (GPX4) and cystine-glutamate antiporter (SLC7A11). This study is based on the hypothesis that Orphan Nuclear Receptor 4A1 (NR4A1) and NR4A2 maintain low levels of Ferroptosis in triple negative breast Cancer (TNBC) cells and bis-indole derived (CDIM) compounds act as NR4A1/2 ligands that induce Ferroptosis by enhancing CD71 expression. 1,1-Bis(3'-indolyl)-1-(3,5-disubstitutedphenyl)methane (DIM-3,5) analogs were investigated for their cytotoxicity and effects on NR4A1 and NR4A2 regulated genes and induction of Ferroptosis. Several assays also determined enhanced lipoperoxidation, Reactive Oxygen Species and malondialdehyde formation in TNBC cells. Knockdown of NR4A1, NR4A2, Sp1 and Sp4 was carried out by RNA interference. Molecular mechanisms of NR4A1/2-mediated regulation of CD71 expression were determined using CD71-luciferase promoter constructs, overexpression of Sp1 and chromatin immunoprecipitation (ChIP) assays. Initial studies show that DIM-3,5 analogs act as an inverse NR4A1/NR4A2 agonists that downregulate the pro-oncogenic responses/gene products regulated by both receptors in TNBC cells. DIM-3,5 analogs also induced ROS, malondialdehyde and lipoperoxide formation in TNBC cells, and this was accompanied by decreased expression of GPX4 and SLC7A11 and induction of CD71. Induction of CD71, an important biomarker of Ferroptosis was observed after treatment of TNBC cells with DIM-3,5 analogs, knockdown of NR4A1, NR4A2, Sp1 or Sp4 demonstrating that induction of CD71 was coregulated by both receptors. Moreover, both promoter and ChIP analysis indicated that NR4A1 and NR4A2 acted as ligand-dependent cofactors of Sp1/4-mediated expression of CD71 in TNBC cells. Thus, CD71, a key biomarker of Ferroptosis is an NR4A1/2/Sp regulated gene that can be directly targeted by DIM-3,5 inverse NR4A1/2 agonists to induce Ferroptosis in TNBC cells.

Figures
Products